 |
|
A New Startup Fund Called EMERTEC
June 20, 2000Cantab Pharmaceuticals plc (LSE: CTB, Nasdaq: CNTBY) today announced the commencement of a Phase I clinical trial of TA-CIN, its novel vaccine candidate for the treatment of cervical dysplasia, an abnormality of the cervix associated with HPV infection, that can lead to cervical cancer if left untreated.
This initial safety and immunogenicity study is being conducted in 40 healthy volunteers at a clinical research centre in The Netherlands, and is designed to assess vaccine safety, tolerability, and to measure immunological responses. Volunteers receive a course of three monthly injections using either a high, medium or low dose formulation.'We are delighted to move TA-CIN into the clinic, after a challenging development programme.
This success now increases the number of Cantab's programmes in the clinic to five,' said Jurek Sikorski, Chief Executive Officer of Cantab. 'Cervical dysplasia affects more than 2% of the female population world-wide, and this vaccine addresses an unmet clinical need for a non-invasive treatment capable of eliminating the underlying cause of the disease.'Dr Nigel Whittle, Director of Project Management, added, 'Cervical dysplasia, which can affect women of all ages, has the potential to develop into a life threatening cancer and can currently only be treated by surgical intervention.
Through the successful development of our TA-CIN vaccine, Cantab aims to offer an effective and less intrusive treatment for cervical dysplasia.'Pre-clinical experimental work using TA-CIN carried out by Cantab in collaboration with the University of Leiden, The Netherlands, has produced encouraging results, with evidence to support both a strong therapeutic and prophylactic effect of the vaccine in animal model studies. Cervical dysplasia is a premalignant condition seen on the surface of the cervix. It is usually identified in women by the standard 'Pap' smear test and can, if left untreated, develop into cervical cancer, a condition that affects an estimated 15,000 women in the USA alone each year, causing up to 4,500 deaths.
The main cause of the disease is believed to be infection with human papillomavirus (HPV).TA-CIN vaccine is based on a genetically engineered fusion protein derived from HPV, and is designed to stimulate the human immune system to destroy cervical cells that are infected with HPV16. This is the type of HPV most commonly found in advanced stages of cervical dysplasia, and is generally considered to be a 'high-risk' type with respect to progression to cancer.
Noonan Russo Ltd
Through the successful development of our TA-CIN vaccine, Cantab aims to offer an effective and less intrusive treatment for cervical dysplasia.'Pre-clinical experimental work using TA-CIN carried out by Cantab in collaboration with the University of Leiden, The Netherlands, has produced encouraging results, with evidence to support both a strong therapeutic and prophylactic effect of the vaccine in animal model studies. Cervical dysplasia is a premalignant condition seen on the surface of the cervix. It is usually identified in women by the standard 'Pap' smear test and can, if left untreated, develop into cervical cancer, a condition that affects an estimated 15,000 women in the USA alone each year, causing up to 4,500 deaths.
The main cause of the disease is believed to be infection with human papillomavirus (HPV).TA-CIN vaccine is based on a genetically engineered fusion protein derived from HPV, and is designed to stimulate the human immune system to destroy cervical cells that are infected with HPV16. This is the type of HPV most commonly found in advanced stages of cervical dysplasia, and is generally considered to be a 'high-risk' type with respect to progression to cancer.
Noonan Russo Ltd
Cervical Cancer Current Events and Cervical Cancer News RSS1 disease, not 1 demographic
The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander."
Alternatively spliced tissue factor identified as promising new biomarker for aggressive cancers
A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists.
M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers
Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center released today the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers.
Study finds delay in follow-up among African-American women receiving abnormal breast finding
A new analysis has identified a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality.
UIC study finds girls aware of HPV vaccine's benefits
Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections.
Scientists identify common HPV genotypes in northern India, encourage vaccination
Although a wide spectrum of human papillomavirus is seen across the population of India, HPV-16 and HPV-18 are the most common types and a vaccination targeting these types could eliminate 75 percent of the cervical cancers in the region.
Vaccinating boys against human papillomavirus not cost-effective
Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer.
Vaccination and testing for the human papilloma virus could eradicate cervical cancer
Cervical cancer could be eradicated within the next 50 years if countries implement national screening programmes based on detection of the human papilloma virus (HPV), which causes the disease, together with vaccination programmes against the virus, according to a cervical cancer screening expert.
Targeted heat therapy offers new standard treatment option for soft tissue sarcoma
Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research.
Even in a safety net health system, colorectal cancer screening disparities remain
Colorectal cancer screening rates are much lower among those in a safety net health system compared to the national average, and the number one predictor of screening is a combination of regular visits and insurance access.
More Cervical Cancer Current Events and Cervical Cancer News Articles
 |
100 Questions & Answers Abourt Cervical Cancer (100 Questions & Answers about . . .) by Don S. Dizon (Author) The only text to provide both the patient and doctor views, 100 Questions & Answers About Cervical Cancer aims to provide a much needed primer for patients and their families and aims to address the questions most relevant to a woman following a diagnosis of pre-invasive changes or invasive cervical cancer. This text gives up-to-date, authoritative, practical answers to your questions about cervical cancer; not only the diagnosis and treatment of the disease, but also female survivorship. This is an invaluable resource for anyone coping with the physical and emotional turmoil of this disease. |
 |
What Every Woman Should Know about Cervical Cancer by Nenad Markovic (Author), Olivera Markovic (Author) Recent introduction of HPV vaccines has raised hopes for immunization against cervical cancer and for the first time in the history of humanity for eradication of one malignant disease. This new âopportunityâ has changed many current views on cervical cancer prevention, control diagnosis and treatment. Many canons and guidelines became subject of review and many revisions are coming. This book is intended to summarize most of these events and to present them to all women in a language understandable by the eneral public. We expect the book will bring all readers the rationale for optimism and will provide guidance as how to gain knowledge and skills for critical thinking and making an educated decision when it will be necessary in their lives. |
 |
Crying in the Shower-Cervical Cancer by Pamela Ayer (Author) My book contains my personal story from the day of detection of cervical cancer until the day I became a cancer survivor. |
 |
Damaged Goods?: Women Living With Incurable Sexually Transmitted Diseases by Adina Nack (Author) How do women living with genital herpes and/or HPV (human papillomavirus) infections see themselves as sexual beings, and what choices do they make about sexual health issues? Adina Nack, a medical sociologist who specializes in sexual health and social psychology, conducted in-depth interviews with 43 women about their identities and sexuality with regard to chronic illness. The result is a fascinating book about an issue that affects millions around the world, but is all too little discussed. "Damaged Goods?" adds to our knowledge of how women are affected by living with chronic STDs and reveals the stages of their sexual self-transformation. From the anxiety of being diagnosed with an STD to issues of blame and shame, Nack - herself diagnosed with a cervical HPV infection - shows why... |
 |
Fight Against Cervical Cancer T-shirt Large White by Shop Zeus |
 |
100 Pack Teal Blue Ribbon Temporary Tattoos for Ovarian Cervical Uterine Cancer Awareness by Palmetto Fundraising Show your courage and support! These teal ribbon tattoos are perfect for your next awareness event. These tattoos make great inspirational giveaways. 100 tattoos per package. Teal ribbon design with clear sides. Approximately 1.5" x 2". These cancer awareness favors are perfect for your awareness fundraisers or event. |
 |
Beating Cervical Cancer Together Keychain by Design a Product LLC Text on keychain: Beating Cervical Cancer Together * Durable acrylic key chain is crystal-clear and double-sided so the artwork or message is seen twice. * Sturdy metal ring holds your keys securely. * Full color printed images or messages are included. * If you have new ideas or need help selecting text for your custom keychains please contact us. * Size: 2 1/8" x 3 1/2" (Approx. business card) |
 |
Say Something! Help End Cervical Cancer 1 DVD and 1 Resource CD Two Cervical Cancer Survivors say something and save lives Editor Producer: Tamika Felder |
 |
Cervical Cancer Awareness Ribbon Mouse Pad by MyHeritageWear.com The Cervical Cancer Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Cervical Cancer Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Cervical Cancer Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
 |
Order of the Eastern Star OES Teal Ribbon Awareness Ovarian Cervical Cancer Pendant Necklace w/chain This is a great Order of the Eastern Star OES / Awareness Ribbon collectible. Show your pride and cause by wearing this great conversation piece. Perfect item for fund raising at your club/lodge. Teal Ribbon : Meaning: This color is a symbol for ovarian, cervical, and uterine cancers as well as sexual assault, polycystic ovarian syndrome, and tsunami victims |
| © 2009 BrightSurf.com |